myTomorrows Surpasses 15,000 Patient Matches through AI-Powered Platform and Personalized Services

myTomorrows New York Netherlands Israel

– to further its commitment to democratizing and improving access to pre-approval treatments.

About myTomorrows

myTomorrows is a global healthtech company dedicated to breaking down barriers for patients seeking treatment options. To make this a reality, the company has built a unique and powerful proprietary technology that conducts a comprehensive and accurate search of clinical trials, and where appropriate, Expanded Access Programs, from global public registries. This functionality efficiently connects patients, physicians, trial sites and BioPharma to simplify and accelerate access to drugs in development. Headquartered in Amsterdam with an office in New York City, myTomorrows has helped more than 15,300 patients and 2,400 physicians across 240+ sites in over 128 countries.

mytomorrows.com

myTomorrows Media Contact:

Kate Schoenstadt
Headline Media
[e-mail]
[phone]

 

View original content:https://www.prnewswire.co.uk/news-releases/mytomorrows-surpasses-15-000-patient-matches-through-ai-powered-platform-and-personalized-services-302460215.html